Showing results (21-30 of 45) with videos related to
Sort By:
Pageof 5
Cancer Treatment Reports|May 1, 1979
Preliminary phase I study of 4'-epi-adriamycinV Bonfante, G Bonadonna, F Villani, et al.Investigational New Drugs|January 1, 1984
Phase I study with 4'-deoxydoxorubicinL Ferrari, A Rossi, C Brambilla, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 1, 1994
Vinorelbine: an active drug for the management of patients with heavily pretreated Hodgkin's diseaseL Devizzi, A Santoro, V Bonfante, et al.Pharmacology, Biochemistry, and Behavior|September 22, 2001
Anticonvulsant preclinical profile of CHF 3381: dopaminergic and glutamatergic mechanismsO Gandolfi, V Bonfante, M Voltattorni, et al.Cancer Treatment Reports|February 1, 1986
Phase II study of doxorubicin versus epirubicin in advanced breast cancerC Brambilla, A Rossi, V Bonfante, et al.Cancer Treatment Reports|March 1, 1986
Salvage chemotherapy in Hodgkin's disease irradiation failures: superiority of doxorubicin-containing regimens over MOPPA Santoro, S Viviani, C J Villarreal, et al.International Journal of Clinical Pharmacology, Therapy, and Toxicology|April 1, 1988
Clinical evaluation of the cardiac toxicity of 4'-deoxy-doxorubicinF Villani, M Galimberti, R Comazzi, et al.Anticancer Research|January 29, 2000
Lung function and serum concentration of tumor necrosis factor-alpha, interleukin-6 and fibronectin in patients treated with ABVD chemotherapy followed by radiotherapy for mediastinal Hodgkin's diseaseF Villani, I Dell'Oca, P De Maria, et al.European Journal of Cancer & Clinical Oncology|November 1, 1986
New anthracycline analogs in advanced breast cancerV Bonfante, L Ferrari, C Brambilla, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 1, 1996
Alternating versus hybrid MOPP and ABVD combinations in advanced Hodgkin's disease: ten-year resultsS Viviani, G Bonadonna, A Santoro, et al.Pageof 5